BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1979900)

  • 1. [Clinical evaluation of bunazosin hydrochloride for the treatment of voiding disturbances due to neurogenic bladder--a double-blind study].
    Koyanagi T; Togashi M; Maru A; Orikasa S; Soma F; Shimazaki J; Yasuda K; Aso Y; Honma Y; Miyake K
    Hinyokika Kiyo; 1990 Oct; 36(10):1233-52. PubMed ID: 1979900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A double-blind trial on the effect of bunazosin hydrochloride for the symptoms of benign prostatic hypertrophy].
    Kumamoto Y; Tsukamoto T; Yachiku S; Kaneko S; Koyanagi T; Togashi M; Maru A; Tsuchida S; Nishizawa O; Orikasa S
    Hinyokika Kiyo; 1990 Oct; 36(10):1213-32. PubMed ID: 1702262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A double-blind trial on the effect of alpha-adrenergic blocker (bunazosin hydrochloride) in the symptomatic treatment of prostatism].
    Kumamoto Y; Yokoyama E; Tsukamoto T; Tsuchida S; Nishizawa O; Koshiba K; Ishibashi A; Ogawa A; Tomita Y; Aso Y
    Hinyokika Kiyo; 1987 Oct; 33(10):1681-702. PubMed ID: 2451409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study of bunazosin hydrochloride, an alpha 1-adrenergic blocker, in benign prostatic obstruction and neurogenic bladder dysfunction].
    Takita T; Kondo A; Mitsuya H; Otani T
    Hinyokika Kiyo; 1987 Sep; 33(9):1375-84. PubMed ID: 2449057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical efficacy of oxendolene (antiandrogen) and bunazosin hydrochloride (alpha-adrenergic blocker) in the treatment of prostatism--comparative study of oxendolone, bunazocin hydrochloride and their combination].
    Kumamoto Y; Tsukamoto T; Takagi Y; Furuya S; Yokoyama E; Takatsuka K; Tamiya T; Miyamoto S; Aoyama T; Honma A
    Hinyokika Kiyo; 1987 Nov; 33(11):1921-41. PubMed ID: 2451412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A double blind clinical trial of the alpha-adrenergic blocker, Ea-0643 tablet, in the treatment of neurogenic bladder].
    Murayama K; Katsumi T; Nakamura T; Tazika E; Sakai A; Haginaka T
    Hinyokika Kiyo; 1985 Oct; 31(10):1845-53. PubMed ID: 2868640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The evaluation of the effects of bunazosin hydrochloride in the treatment of prostatic hyperplasia].
    Fujita T; Ohshima S; Asano H; Ono Y; Kinukawa T; Kato N; Hirabayashi S
    Hinyokika Kiyo; 1992 May; 38(5):613-21. PubMed ID: 1376962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of combination of Ea-0643 (bunazosin hydrochloride) and bethanechol chloride in patients with neurogenic bladder].
    Araki T; Nakano S; Sugimura Y; Tochigi H; Kawamura J; Kato T; Tajima K; Chigusa I; Saito K; Morisita H
    Hinyokika Kiyo; 1990 Nov; 36(11):1379-83. PubMed ID: 1981126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness and safety of bunazosin hydrochloride in neurogenic bladder after prolonged administration].
    Hiraga S; Satoh T; Kakehi R; Kojima S; Yokokawa M; Gotoh S; Kaneoya F; Mizuo T; Tanizawa A; Hosoda K
    Hinyokika Kiyo; 1992 Feb; 38(2):255-63. PubMed ID: 1348604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of long-term administration of oxybutynin hydrochloride (KL007) for the treatment of neurogenic bladder and unstable bladder].
    Sonoda T; Sakurai T; Yamada K; Mizutani S; Tsujimoto Y; Ogawa T
    Hinyokika Kiyo; 1989 Jan; 35(1):167-78. PubMed ID: 2658513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical effects of oxybutynin hydrochloride in the treatment of unstable bladder and overactive neurogenic bladder: a long-term clinical trial].
    Goto M; Kato K; Kondo A; Otani T; Takita T; Kobayashi M
    Hinyokika Kiyo; 1988 Mar; 34(3):541-50. PubMed ID: 3389295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of two alpha-adrenoreceptor antagonists, doxazosin and alfuzosin, in patients with lower urinary tract symptoms from benign prostatic enlargement.
    de Reijke TM; Klarskov P
    BJU Int; 2004 Apr; 93(6):757-62. PubMed ID: 15049986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical effects of oxybutynin hydrochloride on neurogenic bladder].
    Toma H; Nakamura R
    Hinyokika Kiyo; 1986 Jun; 32(6):907-11. PubMed ID: 3532726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical effect of new alpha-adrenergic blocker on micturition disturbance of neurogenic bladder and lower urinary tract obstruction].
    Takimoto Y; Kitamura K; Fuse T; Kawazoe K; Hirano D; Amagai T; Kiyotaki S
    Hinyokika Kiyo; 1983 Feb; 29(2):255-63. PubMed ID: 6145342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical effect of oxybutynin hydrochloride (1 mg/tablet)].
    Yokoyama E; Fujino A; Kubo S; Mashimo S; Koshiba K
    Hinyokika Kiyo; 1990 Jul; 36(7):869-76. PubMed ID: 2239587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical effects of oxybutynin hydrochloride (Pollakis)--especially in the treatment of pollakisuria, urgency and urinary incontinence].
    Yamauchi K; Ohashi K; Osanai H; Inagaki N; Yamaguchi S; Hashimoto H; Yachiku S
    Hinyokika Kiyo; 1990 Dec; 36(12):1485-90. PubMed ID: 2075888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of Cernilton on benign prostatic hypertrophy--a multiple center double-blind study with Paraprost].
    Maekawa M; Kishimoto T; Yasumoto R; Wada S; Harada T; Ohara T; Okajima E; Hirao Y; Ohzono S; Shimada K
    Hinyokika Kiyo; 1990 Apr; 36(4):495-516. PubMed ID: 1696065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of Robaveron tablet (KN-7) in the long-term therapy for urinary disturbances].
    Yamada K; Shiomi T; Momose H; Yamamoto M; Okamura K; Suemori T
    Hinyokika Kiyo; 1985 May; 31(5):901-6. PubMed ID: 4050635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do alpha-blockers have a role in lower urinary tract dysfunction in multiple sclerosis?
    O'Riordan JI; Doherty C; Javed M; Brophy D; Hutchinson M; Quinlan D
    J Urol; 1995 Apr; 153(4):1114-6. PubMed ID: 7869476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.